Trial · NCT01853085
Results by group18
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 18 of 18
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Intraocular Pressure (IOP) in the Study Eye at Baseline | Patients With POAG or OHT | 21.15 | Standard Deviation 3.43 | Millimeters of Mercury (mmHg) | |
| Physician Assessment of IOP-Lowering Effect in the Study Eye on a 3-Point Scale | Patients With POAG or OHT | Better than Expected | 649 | Patients | |
| Physician Assessment of IOP-Lowering Effect in the Study Eye on a 3-Point Scale | Patients With POAG or OHT | As Expected | 916 | Patients | |
| Physician Assessment of IOP-Lowering Effect in the Study Eye on a 3-Point Scale | Patients With POAG or OHT | Worse than Expected | 151 | Patients | |
| Patient Assessment of Tolerability on a 4-Point Scale | Patients With POAG or OHT | Very Good | 913 | Patients | |
| Patient Assessment of Tolerability on a 4-Point Scale | Patients With POAG or OHT | Good | 670 | Patients | |
| Patient Assessment of Tolerability on a 4-Point Scale | Patients With POAG or OHT | Moderate | 73 | Patients | |
| Patient Assessment of Tolerability on a 4-Point Scale | Patients With POAG or OHT | Poor | 74 | Patients | |
| Physician Assessment of Tolerability on a 4-Point Scale | Patients With POAG or OHT | Very Good | 982 | Patients | |
| Physician Assessment of Tolerability on a 4-Point Scale | Patients With POAG or OHT | Good | 648 | Patients | |
| Physician Assessment of Tolerability on a 4-Point Scale | Patients With POAG or OHT | Moderate | 78 | Patients | |
| Physician Assessment of Tolerability on a 4-Point Scale | Patients With POAG or OHT | Poor | 38 | Patients | |
| Number of Patients Who Discontinue Treatment With Lumigan® UD Prior to 12 Weeks of Treatment | Patients With POAG or OHT | 139 | Patients | ||
| Number of Patients Who Continue Treatment | Patients With POAG or OHT | 1501 | Patients | ||
| Physician Assessment of Patient Compliance Compared to Previous Treatment on a 3-Point Scale | Patients With POAG or OHT | Better | 848 | Patients | |
| Physician Assessment of Patient Compliance Compared to Previous Treatment on a 3-Point Scale | Patients With POAG or OHT | Equal | 777 | Patients | |
| Physician Assessment of Patient Compliance Compared to Previous Treatment on a 3-Point Scale | Patients With POAG or OHT | Worse | 50 | Patients | |
| IOP in the Study Eye at Week 12 | Patients With POAG or OHT | 16.38 | Standard Deviation 2.93 | mmHg |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01853085/results